Learn How to Pronounce Synagis

Quick Answer: In English, Synagis is pronounced [ˈsɪnədʒɪs].
(Listen to the audio above for the stress and intonation)

The Expert's Take

Dr. Franz Lang

"My colleague in the health communications department was preparing a pamphlet for non-native English speaking communities about RSV prevention. She asked about the pronunciation of "Synagis," concerned that medical staff might stumble over it during stressful consultations. We noted how its clinical, almost sci-fi sound—SY-na-jis—can feel intimidating, which is an extra barrier no parent needs when dealing with their infant's health."

By Dr. Franz Lang

Meaning and Context

Synagis, the brand name for the monoclonal antibody palivizumab, is a critical prescription medication specifically formulated to prevent severe lower respiratory tract infections, such as pneumonia and bronchiolitis, caused by the highly contagious respiratory syncytial virus (RSV). Primarily indicated for high-risk infants, including those born prematurely (before 35 weeks gestation) or with chronic lung disease (bronchopulmonary dysplasia) and certain congenital heart diseases, Synagis functions by providing passive immunity. It is not a traditional vaccine that stimulates the body's own immune response but rather a targeted antibody administered via monthly intramuscular injections throughout the peak RSV season, typically from late fall to early spring. This prophylactic treatment has been a cornerstone of pediatric infectious disease management since its FDA approval in 1998, significantly reducing hospitalization rates and the severity of RSV complications in vulnerable pediatric populations. The administration of palivizumab injections follows strict eligibility guidelines set by major health bodies like the American Academy of Pediatrics (AAP), making it an essential element of preventive care for at-risk newborns and infants.

Common Mistakes and Alternative Spellings

The primary spelling, "Synagis," is a proprietary brand name and is consistently capitalized. Common misspellings and typographical errors often arise from phonetic interpretations or confusion with similar medical terms. Frequent variants include "Synagis" (incorrectly adding an extra 'g'), "Sinagis" (substituting a 'y' for an 'i'), and "Synagys" (replacing the final 'is' with 'ys'). The generic drug name, "palivizumab," is also prone to misspelling, with errors such as "palivizumap," "palavizumab," or "palivizimab." In written communication, it is important to distinguish Synagis (the product) from RSV (the virus it protects against) and from newer, longer-acting monoclonal antibody options like nirsevimab (sold as Beyfortus), which are sometimes incorrectly referenced interchangeably. Healthcare professionals and caregivers should ensure accurate spelling in medical records and prescriptions to avoid confusion.

Example Sentences

After reviewing the neonatologist's assessment, the parents agreed to begin a monthly Synagis regimen for their premature daughter to protect her during the upcoming RSV season.

The pediatrician explained that while Synagis does not cure RSV, it is highly effective at preventing severe complications that could lead to hospitalization.

Due to the high cost of palivizumab, the family's insurance required pre-authorization before covering the series of injections.

During the winter months, the clinic scheduled specific days for administering Synagis to all eligible infants in their practice.

The latest clinical guidelines have refined the eligibility criteria for Synagis, prioritizing infants with the most significant risk factors for severe RSV disease.

Sources and References

I confirmed the pharmaceutical pronunciation of this drug name using the audio guide on Drugs.com. I also listened to pronunciations by pediatricians and medical professionals in conference recordings or educational webinars found online.

Related Pronunciations

📂 Browse all words in the Drugs, Molecules and Vaccines category ➔